Compare
AbbVie vs Cardinal Health (ABBV vs CAH)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year AbbVie (ABBV) returned +34.4% and Cardinal Health (CAH) +38.1%; so far this year the figures are +27.5% and +32.2%.
AbbVie is the larger company by market value, about 8.2 times the size of Cardinal Health.
On trailing earnings, ABBV trades at 50.1 times and CAH at 37.6 times.
Revenue grew +10.7% at ABBV and +14.2% at CAH over the last year.
ABBV yields 2.38%. CAH yields 0.57%.
Data as of the latest close. Not investment advice.
Relative performance
| ABBV | CAH | |
|---|---|---|
| Price | $291.31 | $271.72 |
| 1-day | +1.07% | +1.46% |
| YTD | +27.49% | +32.22% |
| 1 year | +34.39% | +38.08% |
| 3 years | +104.47% | +190.36% |
| Market cap | $514.9B | $62.8B |
| P/E | 50.1 | 37.6 |
| P/S | 7.80 | 0.25 |
| P/B | — | — |
| Revenue growth | +10.70% | +14.20% |
| EPS growth | +340.20% | — |
| Gross margin % | 73.7 | 3.8 |
| Net margin % | 15.7 | 0.7 |
| ROE % | — | — |
| Debt / equity | — | — |
| FCF yield % | 3.7 | 7.2 |
| Dividend yield % | 2.38 | 0.57 |
| Beta | -0.03 | -0.02 |
| RSI (14) | 59.7 | 73.8 |
| Technical rating |